{"id":78759,"date":"2025-05-14T04:37:06","date_gmt":"2025-05-14T02:37:06","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=78759"},"modified":"2025-05-14T04:37:06","modified_gmt":"2025-05-14T02:37:06","slug":"cholesterolovy-podvod-jak-se-statiny-staly-miliardovym-byznysem-ohrozujicim-lidske-zdravi","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2025\/05\/14\/cholesterolovy-podvod-jak-se-statiny-staly-miliardovym-byznysem-ohrozujicim-lidske-zdravi\/","title":{"rendered":"Cholesterolov\u00fd podvod: Jak se statiny staly miliardov\u00fdm byznysem ohro\u017euj\u00edc\u00edm lidsk\u00e9 zdrav\u00ed"},"content":{"rendered":"<div id=\"fb-root\"><\/div>\n<p><span>L\u00e9ky na cholesterol s n\u00e1zvem statiny byly poprv\u00e9 schv\u00e1leny v roce 1987. Od t\u00e9 doby se rychle staly jednou z nej\u010dast\u011bji p\u0159edepisovan\u00fdch t\u0159\u00edd l\u00e9k\u016f na sv\u011bt\u011b.<\/span><\/p>\n<p><span>V \u010dem spo\u010d\u00edv\u00e1 jejich sl\u00e1va? V tom, \u017ee sni\u017euj\u00ed cholesterol a v \u0161ir\u0161\u00edm smyslu \u00fadajn\u011b chr\u00e1n\u00ed p\u0159ed srde\u010dn\u011b-c\u00e9vn\u00edmi chorobami. Av\u0161ak po v\u00edce ne\u017e t\u0159ech desetilet\u00edch se v\u011bdeck\u00e1 a etick\u00e1 integrita tohoto p\u0159\u00edb\u011bhu rozpad\u00e1.<\/span><\/p>\n<p><span>Cholesterol toti\u017e nen\u00ed jen \u017eivotn\u011b d\u016fle\u017eit\u00fd pro lidsk\u00e9 zdrav\u00ed, ale hraje \u00fast\u0159edn\u00ed roli v synt\u00e9ze hormon\u016f, funkci mozku a imunitn\u00ed odolnosti.<\/span><\/p>\n<p><span>Skute\u010dn\u00e1 \u00fa\u010dinnost statin\u016f byla drasticky nadhodnocena statistick\u00fdmi triky \u2013 manipulac\u00ed s relativn\u00edm sn\u00ed\u017een\u00edm rizika oproti absolutn\u00edmu sn\u00ed\u017een\u00ed rizika.<\/span><\/p>\n<h2><span>Jak se p\u0159ece\u0148uj\u00ed v\u00fdhody statin\u016f: Pochopen\u00ed relativn\u00edho a absolutn\u00edho rizika<\/span><\/h2>\n<p><span>Abychom pochopili, jak byly p\u0159\u00ednosy statin\u016f v\u00fdrazn\u011b nafoukl\u00e9, mus\u00edme si nejprve oz\u0159ejmit, jak je formulov\u00e1na farmaceutick\u00e1 propaganda.<\/span><\/p>\n<p><span>\u0158ekn\u011bme, \u017ee studie zjist\u00ed, \u017ee statiny sni\u017euj\u00ed riziko infarktu o 36%. Zn\u00ed to p\u0159esv\u011bd\u010div\u011b, \u017ee? Toto \u010d\u00edslo v\u0161ak p\u0159edstavuje relativn\u00ed sn\u00ed\u017een\u00ed rizika \u2013 co\u017e je proporcion\u00e1ln\u00ed srovn\u00e1n\u00ed mezi dv\u011bma skupinami. Ne\u0159\u00edk\u00e1 v\u00e1m nic o tom, kolika lidem se skute\u010dn\u011b pomohlo.<\/span><\/p>\n<p><span>Nyn\u00ed se pod\u00edvejme na absolutn\u00ed sn\u00ed\u017een\u00ed rizika, kter\u00e9 n\u00e1m uk\u00e1\u017ee skute\u010dn\u00fd rozd\u00edl v nemocnosti mezi skupinou se statiny a placebem. Nap\u0159\u00edklad:<\/span><\/p>\n<p><span>V jedn\u00e9 studii m\u011bli 2% lid\u00ed ve skupin\u011b se statiny nesmrteln\u00fd infarkt oproti 3% ve skupin\u011b s placebem. Relativn\u00ed sn\u00ed\u017een\u00ed rizika je 33%, vypo\u010dteno jako [(3% \u2013 2%) \/ 3%], ale absolutn\u00ed sn\u00ed\u017een\u00ed rizika bylo pouze 1%, vypo\u010dteno jako (3% \u2013 2%).<\/span><\/p>\n<p><span>To znamen\u00e1, \u017ee 99 ze 100 lid\u00ed, kte\u0159\u00ed u\u017e\u00edvali statiny, nem\u011bli \u017e\u00e1dn\u00fd m\u011b\u0159iteln\u00fd u\u017eitek z hlediska prevence infarktu.<\/span><\/p>\n<p><span>Pou\u017e\u00edv\u00e1n\u00ed relativn\u00edho rizika nen\u00ed jen zav\u00e1d\u011bj\u00edc\u00ed \u2013 hrani\u010d\u00ed s podvodnou komunikac\u00ed v oblasti zdrav\u00ed, zejm\u00e9na pokud se pou\u017e\u00edv\u00e1 k ospravedln\u011bn\u00ed hromadn\u00e9ho p\u0159edepisov\u00e1n\u00ed l\u00e9k\u016f, l\u00e9ka\u0159sk\u00e9ho n\u00e1tlaku a dlouhodob\u00e9 expozice pacienta skupin\u011b l\u00e9k\u016f s v\u00edce ne\u017e 30 zdokumentovan\u00fdmi toxick\u00fdmi \u00fa\u010dinky-<\/span><\/p>\n<h2><span>Dal\u0161\u00ed nep\u0159\u00edjemn\u00fd ukazatel: \u201ePo\u010det pot\u0159ebn\u00fdch k l\u00e9\u010db\u011b (NNT)\u201c<\/span><\/h2>\n<p><span>Dal\u0161\u00edm zp\u016fsobem, jak dok\u00e1zat podvod kolem statin\u016f, je pod\u00edvat se na po\u010det lid\u00ed u\u017e\u00edvaj\u00edc\u00edch l\u00e9k, kte\u0159\u00ed jsou pot\u0159ebn\u00ed k tomu, aby z n\u011bj m\u011bl u\u017eitek jeden \u010dlov\u011bk.<\/span><\/p>\n<p><span>U statin\u016f pou\u017e\u00edvan\u00fdch v prim\u00e1rn\u00ed prevenci (lid\u00e9 bez p\u0159edchoz\u00ed anamn\u00e9zy srde\u010dn\u00edch onemocn\u011bn\u00ed) se tento po\u010det pohybuje od 104 do 250 po dobu p\u011bti let.<\/span><\/p>\n<p><span>\u010cili na ka\u017ed\u00fdch 104 a\u017e 250 lid\u00ed u\u017e\u00edvaj\u00edc\u00edch statiny p\u0159ipadne jeden, kter\u00fd z nich bude m\u00edt u\u017eitek, zat\u00edmco mnoz\u00ed, ne-li v\u0161ichni ostatn\u00ed, budou trp\u011bt ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky.<\/span><\/p>\n<p><span>Porovnejte to s obr\u00e1cen\u00fdm ukazatelem \u2013 po\u010dtem pot\u0159ebn\u00fdch na \u00fajmu (NNH) :<\/span><\/p>\n<ul>\n<li><span>po\u0161kozen\u00ed sval\u016f: 10 a\u017e 20<\/span><\/li>\n<li><span>n\u00e1stup cukrovky: 100 a\u017e 250<\/span><\/li>\n<\/ul>\n<p><span>Jin\u00fdmi slovy, u 10 a\u017e 20 osob u\u017e\u00edvaj\u00edc\u00edch statiny jeden skon\u010d\u00ed s po\u0161kozen\u00fdmi svaly. U 100 a\u017e 250 osob jeden \u010dlov\u011bk skon\u010d\u00ed kv\u016fli statin\u016fm s cukrovkou. Krom\u011b toho statiny po\u0161kozuj\u00ed mozek a kognitivn\u00ed funkce, \u010deho\u017e riziko se zvy\u0161uje s v\u011bkem.<\/span><\/p>\n<p><span>Tato \u010d\u00edsla vykresluj\u00ed pochmurn\u00fd obraz \u2013 statiny v\u00e1m v\u00edce u\u0161kod\u00ed ne\u017e pomohou, zejm\u00e9na pokud je u\u017e\u00edv\u00e1te jen preventivn\u011b, bez p\u0159edchoz\u00ed kardiovaskul\u00e1rn\u00ed p\u0159\u00edhody (infarktu nebo mrtvice).<\/span><\/p>\n<h2><span>Realita sni\u017eov\u00e1n\u00ed rizika u\u017e\u00edv\u00e1n\u00ed statin\u016f<\/span><\/h2>\n<p><span>Studie financovan\u00e9 farmaceutick\u00fdmi spole\u010dnostmi se neust\u00e1le zam\u011b\u0159uj\u00ed na relativn\u00ed riziko s c\u00edlem nafouknout vn\u00edman\u00fd p\u0159\u00ednos, p\u0159i\u010dem\u017e zaml\u010duj\u00ed nebo ignoruj\u00ed \u00fadaje o\u00a0<\/span><a href=\"https:\/\/www.badatel.net\/studia-odhalila-vyse-300-utajovanych-neziaducich-ucinkov-liekov-na-cholesterol\/\"><span>vedlej\u0161\u00edch \u00fa\u010dinc\u00edch<\/span><\/a><span>\u00a0.<\/span><\/p>\n<p><span>Tak\u00e9 \u010dasto vylu\u010duj\u00ed \u00fa\u010dastn\u00edky s negativn\u00edmi reakcemi na l\u00e9k, kte\u0159\u00ed p\u0159ed\u010dasn\u011b ukon\u010dili studii b\u011bhem \u201ez\u00e1b\u011bhov\u00fdch\u201c obdob\u00ed. Tento metodologick\u00fd man\u00e9vr maskuje \u0161kody a vytv\u00e1\u0159\u00ed iluzi bezpe\u010dnosti a \u00fa\u010dinnosti l\u00e9k\u016f.<\/span><\/p>\n<p><span>Krom\u011b toho studie se statiny \u010dasto nedok\u00e1\u017eou posoudit nebo zaznamenat jejich p\u0159\u00ednosy pro \u00famrtnost \u2013 \u00fadajn\u011b jejich nejv\u00fdznamn\u011bj\u0161\u00ed zdravotn\u00ed p\u0159\u00ednos.<\/span><\/p>\n<p><span>V mnoha pr\u016flomov\u00fdch studi\u00edch nebylo pozorov\u00e1no \u017e\u00e1dn\u00e9 v\u00fdznamn\u00e9 sn\u00ed\u017een\u00ed \u00famrtnosti ze v\u0161ech p\u0159\u00ed\u010din u pacient\u016f u\u017e\u00edvaj\u00edc\u00edch statiny ve srovn\u00e1n\u00ed s placebo skupinou, zejm\u00e9na v populac\u00edch s prim\u00e1rn\u00ed prevenc\u00ed.<\/span><\/p>\n<h2><span>Pro\u010d tyto l\u017ei o statinech p\u0159etrv\u00e1vaj\u00ed?<\/span><\/h2>\n<p><span>Zkreslen\u00ed reality na z\u00e1klad\u011b absolutn\u00edch relativn\u00edch p\u0159\u00ednos\u016f p\u0159etrv\u00e1v\u00e1, proto\u017ee:<\/span><\/p>\n<p><span>1. L\u00e9ka\u0159i nejsou dostate\u010dn\u011b vy\u0161koleni v l\u00e9ka\u0159sk\u00e9 statistice a v\u011bt\u0161ina z nich d\u016fv\u011b\u0159uje pokyn\u016fm a prohl\u00e1\u0161en\u00edm z\u00e1stupc\u016f farmaceutick\u00fdch firem.<\/span><\/p>\n<p><span>2. Pacienti nejsou nikdy informov\u00e1ni, \u017ee \u201eo 36% m\u00e9n\u011b infarkt\u016f\u201c m\u016f\u017ee znamenat pouze \u201eo 1 osobu m\u00e9n\u011b ze 100\u201c.<\/span><\/p>\n<p><span>3. Medic\u00ednsk\u00e9 \u010dasopisy a m\u00e9dia \u010dasto opakuj\u00ed tiskov\u00e9 zpr\u00e1vy farmaceutick\u00fdch firem, ani\u017e by p\u0159ezkoumaly skute\u010dn\u00e1 \u010d\u00edsla.<\/span><\/p>\n<p><span>Tato manipulace umo\u017e\u0148uje statin\u016fm z\u016fstat \u00fasp\u011b\u0161n\u00fdm l\u00e9kem navzdory rostouc\u00edmu po\u010dtu d\u016fkaz\u016f o tom, \u017ee \u0161kody p\u0159eva\u017euj\u00ed nad p\u0159\u00ednosy pro drtivou v\u011bt\u0161inu jejich u\u017eivatel\u016f.<\/span><\/p>\n<h2><span>Lep\u0161\u00ed model: Transparentnost, informovan\u00fd souhlas a p\u0159irozen\u00e9 alternativy<\/span><\/h2>\n<p><span>Je \u010das odm\u00edtnout manipulativn\u00ed statistiku a obnovit biologickou gramotnost v medic\u00edn\u011b. Kardiovaskul\u00e1rn\u00ed choroby jsou multikauz\u00e1ln\u00edm z\u00e1n\u011btliv\u00fdm onemocn\u011bn\u00edm, ne probl\u00e9mem s cholesterolem.<\/span><\/p>\n<p><span>Potla\u010dov\u00e1n\u00ed cholesterolu a z\u00e1rove\u0148 naru\u0161ov\u00e1n\u00ed v\u00edce ne\u017e 30 bun\u011b\u010dn\u00fdch syst\u00e9m\u016f nen\u00ed zdrav\u00ed \u2013 je to potla\u010dov\u00e1n\u00ed p\u0159\u00edznak\u016f prost\u0159ednictv\u00edm biochemick\u00e9ho n\u00e1sil\u00ed.<\/span><\/p>\n<p><span>Mezi \u00fa\u010dinn\u00e9 p\u0159irozen\u00e9 prost\u0159edky p\u0159i proti vysok\u00e9mu cholesterolu podlo\u017een\u00e9 re\u00e1ln\u00fdmi v\u00fdsledky pat\u0159\u00ed l\u00e1tky jako:<\/span><\/p>\n<ul>\n<li><span>koenzym Q10 \u2013 nezbytn\u00fd pro zdrav\u00ed mitochondri\u00ed, vy\u010derp\u00e1van\u00fd statiny<\/span><\/li>\n<li><span>\u010derven\u00e1 kva\u0161en\u00e1 r\u00fd\u017ee \u2013 p\u0159\u00edrodn\u00ed alternativa statin\u016f, ale vy\u017eaduje pe\u010dlivou p\u0159\u00edpravu<\/span><\/li>\n<li><span>vitam\u00edn K2 \u2013 zabra\u0148uje vaskul\u00e1rn\u00ed kalcifikaci, zejm\u00e9na u u\u017eivatel\u016f statin\u016f<\/span><\/li>\n<li><span>omega-3 mastn\u00e9 kyseliny \u2013 sni\u017euj\u00ed triglyceridy a syst\u00e9mov\u00fd z\u00e1n\u011bt<\/span><\/li>\n<\/ul>\n<p><span>Tak\u00e9 nesm\u00edme zapomenout na prevenci zalo\u017een\u00e1 na \u017eivotn\u00edm stylu \u2013 strava, pohyb, dechov\u00e1 cvi\u010den\u00ed, sp\u00e1nek a emocion\u00e1ln\u00ed l\u00e9\u010den\u00ed. V\u0161echny tyto v\u011bci maj\u00ed prokazateln\u00fd vliv na sn\u00ed\u017een\u00ed rizika srde\u010dn\u00edch onemocn\u011bn\u00ed.<\/span><\/p>\n<p><span>\u017d\u00e1dn\u00e1 z t\u011bchto v\u011bc\u00ed nevy\u017eaduje zkreslov\u00e1n\u00ed statistik ani potla\u010den\u00ed p\u0159\u00edznak\u016f. Funguj\u00ed tak, \u017ee podporuj\u00ed inteligenci t\u011bla a ne aby ji potla\u010dovaly.<\/span><\/p>\n<h2><span>Ochrann\u00e1 s\u00edla cholesterolu: Nezn\u00e1m\u00fd hrdina p\u0159\u00edrody<\/span><\/h2>\n<p><span>S t\u00edm, jak za\u010d\u00edn\u00e1 rozpl\u00fdvat p\u0159\u00edb\u011bh kolem statin\u016f, mus\u00ed se rozplynout i m\u00fdtus, \u017ee n\u00edzk\u00fd cholesterol znamen\u00e1 lep\u0161\u00ed zdrav\u00ed. Cholesterol nen\u00ed jen nezbytn\u00fd \u2013 je tak\u00e9 pot\u0159ebn\u00fd a ochrann\u00fd.<\/span><\/p>\n<p><span>Cholesterol m\u00e1 antimikrobi\u00e1ln\u00ed vlastnosti, podporuje neuroplasticitu (vytv\u00e1\u0159en\u00ed nov\u00fdch nervov\u00fdch spojen\u00ed v mozku) a je nezbytn\u00fd pro opravu po\u0161kozen\u00fdch tk\u00e1n\u00ed.<\/span><\/p>\n<p><span>\u010cetn\u00e9 studie spojuj\u00ed n\u00edzk\u00fd cholesterol se zv\u00fd\u0161en\u00fdm rizikem rakoviny, deprese, agrese a hemoragick\u00e9 mozkov\u00e9 p\u0159\u00edhody.<\/span><\/p>\n<p><span>Cholesterol je tak\u00e9 prvn\u00ed reaguj\u00edc\u00ed l\u00e1tkou na c\u00e9vn\u00ed po\u0161kozen\u00ed, \u010dili p\u016fsob\u00ed jako biologick\u00e1 n\u00e1plast na po\u0161kozen\u00ed v\u00fdstelky c\u00e9v endotelu \u2013 ne jako jeho p\u0159\u00ed\u010dina.<\/span><\/p>\n<p><span>Potla\u010den\u00edm t\u00e9to multifunk\u010dn\u00ed molekuly mohou statiny oslabit p\u0159irozen\u00e9 obrann\u00e9 syst\u00e9my t\u011bla. Pacient tak sice na pap\u00ed\u0159e z\u00edsk\u00e1 sn\u00ed\u017een\u00ed n\u011bjak\u00fdch abstraktn\u00edch biomarker\u016f, ale zaplat\u00ed za to poklesem sv\u00e9 skute\u010dn\u00e9 fyziologick\u00e9 odolnosti.<\/span><\/p>\n<h2><span>Z\u00e1v\u011br<\/span><\/h2>\n<p><span>T\u00e9matu vysok\u00e9ho cholesterolu a p\u0159\u00edrodn\u00edm zp\u016fsobem \u010di\u0161t\u011bn\u00ed zanesen\u00fdch c\u00e9v se samostatn\u011b v\u011bnujeme v elektronick\u00e9 knize, kterou jsme p\u0159ed \u010dasem publikovali. V\u00edce informac\u00ed o n\u00ed najdete\u00a0<\/span><a href=\"https:\/\/eknihy.shop\/koniec-vysokemu-cholesterolu-a-upchatym-cievam-prirodna-liecba\/\"><strong><span>ZDE<\/span><\/strong><\/a><span>\u00a0ao \u010desk\u00e9 verzi e-knihy\u00a0<\/span><a href=\"https:\/\/eknihy.shop\/konec-vysokemu-cholesterolu-a-ucpanym-cevam-prirodni-lecba\/\"><strong><span>ZDE<\/span><\/strong><\/a><span>\u00a0.<\/span><\/p>\n<p><span>V knize se dozv\u00edte v\u011bci jako nap\u0159\u00edklad to, jak\u00e9 jsou p\u0159\u00edznaky ucpan\u00fdch c\u00e9v, jak\u00e1 jsou v\u0161echna rizika l\u00e9k\u016f proti cholesterolu (statin\u016f), co d\u011blat, pokud v\u00e1m l\u00e9ka\u0159 nechce dovolit tyto l\u00e9ky vysadit, jak\u00e1 je pravda o n\u00edzkotu\u010dn\u00e9 strav\u011b, co\u017e je skute\u010dn\u00e1 p\u0159\u00ed\u010dina ucp\u00e1v\u00e1n\u00ed c\u00e9v. informac\u00ed.<\/span><\/p>\n<p><span>Zdroj:\u00a0<\/span><a href=\"https:\/\/greenmedinfo.com\/content\/cholesterol-con-how-statins-became-billion-dollar-threat-human-health\" target=\"_blank\" rel=\"noopener\"><span>greenmedinfo.com<\/span><\/a><span>\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u00e9ky na cholesterol s n\u00e1zvem statiny byly poprv\u00e9 schv\u00e1leny v roce 1987. Od t\u00e9 doby&#8230;<\/p>\n","protected":false},"author":2,"featured_media":78760,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[6252,1020,497,9119,21],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/78759"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=78759"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/78759\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/78760"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=78759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=78759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=78759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}